nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial

BACKGROUND: Limited data on elderly patients with squamous advanced non-small cell lung cancer (NSCLC) preclude optimal treatment. Here, we report the outcomes of a retrospective analysis of a subset of patients ≥70 years with squamous histology from the Phase III trial that evaluated nab-paclitaxel...

Descripción completa

Detalles Bibliográficos
Autores principales: Gridelli, Cesare, Chen, Tianlei, Ko, Amy, O’Brien, Mary E, Ong, Teng Jin, Socinski, Mark A, Postmus, Pieter E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973475/
https://www.ncbi.nlm.nih.gov/pubmed/29872267
http://dx.doi.org/10.2147/DDDT.S155750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973475/
https://www.ncbi.nlm.nih.gov/pubmed/29872267
http://dx.doi.org/10.2147/DDDT.S155750

Ejemplares similares